The Early Detection Research Network: 10-Year Outlook
Author(s) -
Sudhir Srivastava
Publication year - 2012
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2012.184697
Subject(s) - clinical trial , food and drug administration , drug development , multidisciplinary approach , clearance , process (computing) , medicine , quality (philosophy) , biomarker , medical physics , computer science , data science , risk analysis (engineering) , pathology , social science , philosophy , drug , epistemology , psychiatry , sociology , urology , operating system , biochemistry , chemistry
The National Cancer Institute's Early Detection Research Network (EDRN) has made significant progress in developing an organized effort for discovering and validating biomarkers, building resources to support this effort, demonstrating the capabilities of several genomic and proteomic platforms, identifying candidate biomarkers, and undertaking multicenter validation studies. In its first 10 years, the EDRN went from a groundbreaking concept to an operational success.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom